Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, United States.
Front Immunol. 2024 Jul 30;15:1426204. doi: 10.3389/fimmu.2024.1426204. eCollection 2024.
Autophagy is a regulated intracellular catabolic process by which invading pathogens, damaged organelles, aggregated proteins, and other macromolecules are degraded in lysosomes. It has been widely appreciated that autophagic activity plays an important role in regulating the development, fate determination, and function of cells in the immune system, including B lymphocytes. Autophagy encompasses several distinct pathways that have been linked to B cell homeostasis and function. While B cell presentation of major histocompatibility complex (MHC) class II-restricted cytosolic antigens to T cells involves both macroautophagy and chaperone-mediated autophagy (CMA), plasma cells and memory B cells mainly rely on macroautophagy for their survival. Emerging evidence indicates that core autophagy factors also participate in processes related to yet clearly distinct from classical autophagy. These autophagy-related pathways, referred to as noncanonical autophagy or conjugation of ATG8 to single membranes (CASM), contribute to B cell homeostasis and functions, including MHC class II-restricted antigen presentation to T cells, germinal center formation, plasma cell differentiation, and recall responses. Dysregulation of B cell autophagy has been identified in several autoimmune and autoinflammatory diseases such as systemic lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease. In this review, we discuss recent advances in understanding the role of canonical and noncanonical autophagy in B cells, including B cell development and maturation, antigen processing and presentation, pathogen-specific antibody responses, cytokine secretion, and autoimmunity. Unraveling the molecular mechanisms of canonical and noncanonical autophagy in B cells will improve our understanding of B cell biology, with implications for the development of autophagy-based immunotherapies.
自噬是一种受调控的细胞内分解代谢过程,通过该过程,入侵病原体、受损细胞器、聚集的蛋白质和其他大分子在溶酶体中被降解。自噬活性在调节免疫系统中细胞的发育、命运决定和功能方面起着重要作用,这一观点已得到广泛认可,包括 B 淋巴细胞。自噬包含几种不同的途径,这些途径与 B 细胞的稳态和功能有关。虽然 B 细胞将主要组织相容性复合体(MHC)Ⅱ类限制的细胞溶质抗原呈递给 T 细胞涉及巨自噬和伴侣介导的自噬(CMA),但浆细胞和记忆 B 细胞主要依赖巨自噬来维持其生存。新出现的证据表明,核心自噬因子也参与了与经典自噬明显不同但又相关的过程。这些自噬相关途径,称为非经典自噬或 ATG8 与单膜的缀合(CASM),有助于 B 细胞的稳态和功能,包括 MHC Ⅱ类限制的抗原呈递给 T 细胞、生发中心形成、浆细胞分化和回忆反应。在几种自身免疫和自身炎症性疾病中,如系统性红斑狼疮、类风湿关节炎和炎症性肠病中,已经鉴定出 B 细胞自噬的失调。在这篇综述中,我们讨论了在理解经典和非经典自噬在 B 细胞中的作用方面的最新进展,包括 B 细胞的发育和成熟、抗原加工和呈递、病原体特异性抗体反应、细胞因子分泌和自身免疫。阐明 B 细胞中经典和非经典自噬的分子机制将提高我们对 B 细胞生物学的理解,为基于自噬的免疫疗法的发展提供启示。